HLS Therapeutics (74D.F) Q1 2025 Earnings

13MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.18
-0.14
-0.11
-0.08

Details

Expected EPS
-0.08143667875
Actual EPS
-0.09214900000000001
Surprise EPS
-0.01
Surprise Percent
+13.15%

Description

HLS Therapeutics (74D.F) has reported earnings of -0.09214900000000001 per share for Q1 2025.

0 Comments

Share your thoughts